Follow
Stefan Gross
Stefan Gross
Servier Pharmaceuticals
Verified email at servier.com
Title
Cited by
Cited by
Year
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
L Dang, DW White, S Gross, BD Bennett, MA Bittinger, EM Driggers, ...
Nature 462 (7274), 739-744, 2009
45682009
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation
F Wang, J Travins, B DeLaBarre, V Penard-Lacronique, S Schalm, ...
Science 340 (6132), 622-626, 2013
9352013
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
S Gross
Journal of Experimental Medicine 207 (2), 339-334, 2010
8702010
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
P Koivunen, S Lee, CG Duncan, G Lopez, G Lu, S Ramkissoon, ...
Nature 483 (7390), 484-488, 2012
8212012
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
K Yen, J Travins, F Wang, MD David, E Artin, K Straley, A Padyana, ...
Cancer discovery 7 (5), 478-493, 2017
4132017
Discovery of AG-120 (Ivosidenib): a first-in-class mutant IDH1 inhibitor for the treatment of IDH1 mutant cancers
J Popovici-Muller, RM Lemieux, E Artin, JO Saunders, FG Salituro, ...
ACS medicinal chemistry letters 9 (4), 300-305, 2018
3822018
MTAP deletions in cancer create vulnerability to targeting of the MAT2A/PRMT5/RIOK1 axis
K Marjon, MJ Cameron, P Quang, MF Clasquin, E Mandley, K Kunii, ...
Cell reports 15 (3), 574-587, 2016
3422016
Hrp1, a sequence-specific RNA-binding protein that shuttles between the nucleus and the cytoplasm, is required for mRNA 3′-end formation in yeast
MM Kessler, MF Henry, E Shen, J Zhao, S Gross, PA Silver, CL Moore
Genes & development 11 (19), 2545-2556, 1997
3061997
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo
J Popovici-Muller, JO Saunders, FG Salituro, JM Travins, S Yan, F Zhao, ...
ACS medicinal chemistry letters 3 (10), 850-855, 2012
2402012
Small molecule activation of PKM2 in cancer cells induces serine auxotrophy
C Kung, J Hixon, S Choe, K Marks, S Gross, E Murphy, B DeLaBarre, ...
Chemistry & biology 19 (9), 1187-1198, 2012
1932012
Coupling of termination, 3′ processing, and mRNA export
CM Hammell, S Gross, D Zenklusen, CV Heath, F Stutz, C Moore, ...
Molecular and cellular biology, 2002
1742002
Full-length human glutaminase in complex with an allosteric inhibitor
B DeLaBarre, S Gross, C Fang, Y Gao, A Jha, F Jiang, J Song J, W Wei, ...
Biochemistry 50 (50), 10764-10770, 2011
1622011
Five subunits are required for reconstitution of the cleavage and polyadenylation activities of Saccharomyces cerevisiae cleavage factor I
S Gross, C Moore
Proceedings of the National Academy of Sciences 98 (11), 6080-6085, 2001
1342001
MAT2A inhibition blocks the growth of MTAP-deleted cancer cells by reducing PRMT5-dependent mRNA splicing and inducing DNA damage
P Kalev, ML Hyer, S Gross, Z Konteatis, CC Chen, M Fletcher, M Lein, ...
Cancer Cell 39 (2), 209-224. e11, 2021
1202021
Rna15 interaction with the A-rich yeast polyadenylation signal is an essential step in mRNA 3′-end formation
S Gross, CL Moore
Molecular and cellular biology 21 (23), 8045-8055, 2001
1132001
Mutant IDH is sufficient to initiate enchondromatosis in mice
M Hirata, M Sasaki, RA Cairns, S Inoue, V Puviindran, WY Li, BE Snow, ...
Proceedings of the National Academy of Sciences 112 (9), 2829-2834, 2015
1042015
AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency
C Kung, J Hixon, PA Kosinski, G Cianchetta, G Histen, Y Chen, C Hill, ...
Blood, The Journal of the American Society of Hematology 130 (11), 1347-1356, 2017
1022017
Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase
AK Padyana, S Gross, L Jin, G Cianchetta, R Narayanaswamy, F Wang, ...
Nature communications 10 (1), 97, 2019
1012019
Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1
MI Davis, S Gross, M Shen, KS Straley, R Pragani, WA Lea, ...
Journal of Biological Chemistry 289 (20), 13717-13725, 2014
932014
ALDH2 (E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis
S Jin, J Chen, L Chen, G Histen, Z Lin, S Gross, J Hixon, Y Chen, C Kung, ...
Proceedings of the National Academy of Sciences 112 (29), 9088-9093, 2015
892015
The system can't perform the operation now. Try again later.
Articles 1–20